Literature DB >> 25696140

Arrhythmogenic right ventricular dysplasia/cardiomyopathy: new avenues for diagnosis and treatment.

E E van der Wall, M Bootsma, H J J Wellens, J J Bax, A de Roos, M J Schalij.   

Abstract

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a heart muscle disorder of unknown course that is characterised pathologically by fatty or fibrofatty replacement of the right ventricular myocardium and electrical instability. Clinical manifestations include structural and functional malformations of the right ventricle, electrocardiographic abnormalities, and presentation of ventricular tachycardias with left bundle branch pattern or sudden death. The disease is often familial with an autosomal inheritance. In addition to right ventricular dilatation, right ventricular aneurysms are typical deformities of ARVD/C and they are distributed in the so-called 'triangle of dysplasia', i.e. the right ventricular outflow tract, apex and infundibulum. Ventricular aneurysms at these sites can be considered highly suggestive for ARVD/C. Another typical hallmark of ARVD/C is fatty or fibrofatty infiltration of the right ventricular free wall with potential extension to the left ventricle. These functional and morphological characteristics are relevant to clinical imaging investigations such as contrast angiography, echocardiography, radionuclide angiography, ultrafast-computed tomography and magnetic resonance (MR) imaging. Among these techniques, MR imaging allows the most comprehensive assessment of the heart, in particular because it provides functional and flow-dynamic information in addition to anatomic images. Furthermore, MR imaging offers the specific advantage of visualising adipose infiltration as a bright signal of the right ventricular myocardium. Non-pharmacological treatment by radio-frequency ablation and implantable defibrillators will play an increasing role in the treatment of patients with ARVD/C, especially in case of drug ineffectivity. Despite new diagnostic and therapeutic approaches in ARVD/C, there remain many unanswered issues since the current guidelines present criteria that are highly specific but lack sensitivity. Therefore, optimal assessment of diagnostic criteria would require a prospective evaluation from a large population obtained by an international registry.

Entities:  

Keywords:  arrhythmias; cardiomyopathy; dysplasia; fatty infiltration; imaging modalities; left bundle branch block; registry; right ventricle; treatment

Year:  2003        PMID: 25696140      PMCID: PMC2499826     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  149 in total

1.  Arrhythmogenic right ventricular cardiomyopathy with an initial manifestation of severe left ventricular impairment and normal contraction of the right ventricle.

Authors:  G Fontaine; P Fornes; D Chemla
Journal:  Jpn Circ J       Date:  2000-09

Review 2.  Endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy.

Authors:  A Angelini; C Basso; A Nava; G Thiene
Journal:  Am Heart J       Date:  1996-07       Impact factor: 4.749

3.  Right ventricular arrhythmia: emergence of magnetic resonance imaging as an investigative tool.

Authors:  D Pennell; G Casolo
Journal:  Eur Heart J       Date:  1997-12       Impact factor: 29.983

4.  Significance of morphological abnormalities detected by MRI in patients undergoing successful ablation of right ventricular outflow tract tachycardia.

Authors:  S Globits; G Kreiner; H Frank; G Heinz; U Klaar; B Frey; H Gössinger
Journal:  Circulation       Date:  1997-10-21       Impact factor: 29.690

5.  Adipose dysplasia of the right ventricle: is endomyocardial biopsy useful?

Authors:  J Strain
Journal:  Eur Heart J       Date:  1989-09       Impact factor: 29.983

Review 6.  Arrhythmogenic right ventricular dysplasia: MRI findings.

Authors:  E E van der Wall; H W Kayser; M M Bootsma; A de Roos; M J Schalij
Journal:  Herz       Date:  2000-06       Impact factor: 1.443

7.  Evaluation of signal-averaged electrocardiography for clinical diagnosis in arrhythmogenic right ventricular dysplasia.

Authors:  K Sekiguchi; Y Miya; Y Kaneko; T Kanda; Y Fukumura; N Kotajima; J Tamura; I Kobayashi
Journal:  Jpn Heart J       Date:  2001-05

8.  Screening for hypertrophic cardiomyopathy in young athletes.

Authors:  D Corrado; C Basso; M Schiavon; G Thiene
Journal:  N Engl J Med       Date:  1998-08-06       Impact factor: 91.245

9.  Echocardiographic and histologic evaluation of the right ventricle in ventricular tachycardias of left bundle branch block morphology without overt cardiac abnormality.

Authors:  D Mehta; H Odawara; D E Ward; W J McKenna; M J Davies; A J Camm
Journal:  Am J Cardiol       Date:  1989-04-15       Impact factor: 2.778

10.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?

Authors:  C Basso; G Thiene; D Corrado; A Angelini; A Nava; M Valente
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.